Basic Information
Patrys was listed on the Australian Securities Exchange (ASX) in 2007, developing novel antibody therapies for the treatment of cancer. In 2016, Patrys obtained a worldwide exclusive license from Yale University to use deoxymab antibodies as human therapeutic agents for the treatment and management of cancer.
Patrys Limited
Melbourne,Victoria,Australia
unclear
January 01, 2006
--
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios